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Summary
Objective: The death of chondrocytes by apoptosis is characteristic of degenerative joint diseases, such as osteoarthritis (OA). Tumor
necrosis factor-a (TNF-a) and interleukin-1b (IL-1b) have been shown to play an important role in the development of OA. In this study we
analyzed the effects of TNF-a and IL-1b on cell death in normal human chondrocytes.
Methods: Normal human chondrocytes were isolated from knee cartilage obtained at autopsy from 30 adult cadaveric donors. The cells were
stimulated with TNF-a (10 ng/ml) or IL-1b (5 ng/ml) in the presence or absence of Ro 31-8220 (Ro: a structurally related analog of bisindo-
lylmaleimide that inhibits mitogen-activated protein kinase phosphatase 1 [MKP-1]) (Ro; 10 mM), an MKP-1 inhibitor, which induces apoptosis
in chondrocytes. Apoptosis was evaluated by ﬂow cytometry (propidium iodide) and nuclear morphology was evaluated with 40,60-dianidino-2-
phenylindole dihydrochloride. The expressions of caspase-8, -7 and -3 and Bcl-2 were analyzed by Western blot and the activation of
caspase-3 and -8 was measured by ﬂow cytometry. Prostaglandin E2 (PGE2) was evaluated by enzyme-linked immunosorbent assay.
Results: At 24 h the percentage of apoptotic (hypodiploid) nuclei induced by TNF-aþRo was higher than the level induced by Ro alone. The
combination of IL-1b (5 ng/ml) with Ro did not show a synergistic effect. A morphological analysis demonstrated that treatment with TNF-aþRo
resulted in a large number of cells with condensed nuclei and DNA fragmentation. Western blot studies indicated that IL-1bþRo did not induce
the time-dependent activation of caspase-8, -7 and -3 as seen with TNF-aþRo. As quantiﬁed by ﬂow cytometry, TNF-aþRo induced a higher
level of caspase-3 and -8 activation than that seen with IL-1bþRo. Pre-incubation for 2 h with caspase inhibitors for caspase-3, -7, -8 and pan-
caspase signiﬁcantly decreased the hypodiploid DNA peak induced by treatment with TNF-aþRo at 24 h. Indomethacin increased the cell
death induced by IL-1bþRo; however, apoptosis induced by TNF-aþRo was not modiﬁed by indomethacin.
Conclusions: These results conﬁrm that TNF-a and IL-1b regulate apoptosis differently in this human chondrocyte model and that the differing
effects of these cytokines are PGE2-independent. Indomethacin potentiates the effect of IL-1 on cell death and this may explain the reported
effect of indomethacin on the progression of joint destruction.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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In most human articular diseases, chondrocyte death, and
the resulting reduction of tissue cellularity, may be an impor-
tant step in the pathogenesis of cartilage destruction1,2. The
cytokines, interleukin-1b (IL-1b) and tumor necrosis factor-
a (TNF-a), are particularly important in the pathophysiology
of cartilage disease. Both in vitro and in vivo studies
showed that the effects of TNF-a were similar to or syner-
gistic with those of IL-1b3. However, the precise roles that
TNF-a and IL-1b play in chondrocyte survival remain un-
known4. Chondrocytes are normally resistant to the induc-
tion of apoptosis by IL-1b or TNF-a stimulation5. It has
also been reported that IL-1b protects chondrocytes from
CD95-induced apoptosis by a mechanism that is indepen-
dent of IL-1b-induced nitric oxide (NO)5. However,*Address correspondence and reprint requests to: Dr Francisco
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715conﬂicting results have been reported indicating that IL-
1b-induced apoptosis in human articular chondrocytes6.
The induction of chondrocyte apoptosis by TNF-a is uncer-
tain because of differing results of several studies.
These results suggest that the pro- or anti-apoptotic ef-
fects of IL-1b or TNF-a may depend upon the experimental
model. Differences in culture conditions (e.g., cell density,
cell lines, monolayer or alginate beads) and the age of
cartilage samples used for cell culture may contribute to
this controversy. We recently described that TNF-a and
IL-1b differently regulate activation of the apoptotic chon-
drocyte pathway in an in vitro model of apoptosis induced
by actinomycin D (ActD) a DNA-dependent RNA polymer-
ase inhibitor7. We demonstrated that this difference could
be largely dependent on prostaglandin and caspase-8
levels. One signiﬁcant aspect of this work is that the rela-
tionship between two key cytokines in the pathophysiology
of articular disease and chondrocyte death was tested in
the same experimental model and with the same culture
conditions.
The current hypothesis to explain how cytokines can
selectively kill some cells, while not being harmful to others,
involves the operation of two opposite signaling pathways:
a pre-existing destructive (apoptotic) pathway and an
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tween the two pathways, and particularly the balance of
their activities, determine whether the cells survive or die8.
Recently, signiﬁcant progress has been made in clarifying
the mechanism of apoptosis induced by cytokines, includ-
ing TNF-a and IL-1. However, the identities of the protective
factors induced by TNF-a or IL-1 and their mechanisms
of action remain elusive. For example, TNF-a activation of
extracellular signal-regulated protein kinase (ERK) and
nuclear factor-kB (NF-kB) appears to counteract the
cytotoxicity of the apoptotic pathway in certain cells9,10,
but not in others11,12.
Some of the putative protective factors identiﬁed thus far
include a manganese superoxide dismutase13, a zinc ﬁnger
protein14, and members of the Bcl-2 family of proteins15,16.
Mitogen-activated protein kinase (MAPK) phosphatase 1
(MKP-1) may act as a protective factor against apoptosis
by suppressing the activation of c-Jun N-terminal kinase
(JNK)17. MKP-1 down-regulation has been correlated to ap-
optosis induction in human chondrocytes18. Therefore,
stimulation of cells with TNF-aþRo 31-8220 (Ro: a structur-
ally related analog of bisindolylmaleimide that inhibitsMKP-1)
may be useful as an in vitromodel to study apoptosis. Given
the complexity of the signaling pathways of cytokines, it is ap-
parent that several protective factorsmay exert anti-apoptotic
effects through a variety of mechanisms andmay act at differ-
ent stages of the apoptotic process in amanner dependent on
cell type and stimulus.
In this study we activated the apoptotic pathways of hu-
man articular chondrocytes by culturing them with Ro. Our
study demonstrates that TNF-a and IL-1b, in combination
with an inhibitor of MKP-1, regulate the activation of the ap-
optotic pathway in human chondrocytes differently and that
PGE2 is not a protective factor against the induction of ap-
optosis in human articular chondrocytes. These ﬁndings
provide new clues for the understanding of cartilage degra-
dation in articular disease.
MethodsCHONDROCYTE CULTURESNormal human cartilage was obtained at autopsy from 30 adult cadaveric
donors with no history of joint disease [inﬂammatory arthritis, osteoarthritis
(OA), microcrystalline arthritis or osteonecrosis]. Under aseptic conditions,
cartilage slices were removed from the condyles, minced and treated with
trypsin (0.5 mg/ml) (SigmaeAldrich, St. Louis, MO, USA) for 15 min at
37C. After the cartilage was removed from the trypsin it was treated over-
night with 2 mg/ml clostridial collagenase (SigmaeAldrich) in Dulbecco’s
modiﬁed Eagle’s medium (DMEM; Life Technology, Paisley, UK) in an orbital
shaker at 37C. The digest was centrifuged and the cells were resuspended
in fetal calf serum (FCS)-enriched DMEM for culture in ﬂasks. Subcultures
were performed with trypsin-ethylenediaminetetraacetic acid (EDTA) (Gibco,
Paisley, UK) and ﬁrst passage cells were used. This study was approved by
the Ethics Committee of Galicia e Spain.CELL STIMULATION OF CHONDROCYTESChondrocytes were seeded into tissue culture plates (200 mm; Costar,
Corning, NY, USA) for total protein extraction, six-well plates (Costar) for
ﬂow cytometric analysis and eight-well slides for morphological studies. Cells
were rendered quiescent by 48 h of incubation in medium containing 0.5%
FCS, washed and then stimulated with TNF-a (10 ng/ml) (R&D Systems,
Europe) or IL-1b (5 ng/ml) (SigmaeAldrich), in the presence or absence of
Ro 31-8220 (Ro; 10 mM) (SigmaeAldrich). Some cells were pre-incubated
for 2 h with inhibitors of the caspases: caspase-3 inhibitor (Z-DEVD-FMK,
100 mM; BD Pharmmigen, Heidelberg, Germany), caspase-8 inhibitor
(Z-IETD-FMK, 100 mM; BD); caspase-3 and caspase-7 inhibitor (5-[(S)-()-
2-(Methoxymethyl)pyrrolidino]sulfonylisatin, 100 mM; Calbiochem, VWR In-
ternational, Spain); general caspase inhibitor (Z-VAD-FMK, 100 mM; BD),
a caspase-1 inhibitor (100 mM; BD); or an inhibitor of cyclooxygenase
(COX) (indomethacin, SigmaeAldrich). The cells were then stimulated with
cytokines.FLOW CYTOMETRIC ASSESSMENT OF CELL DEATHCellular DNA content was assessed by ﬂow cytometry, as previously de-
scribed1. For this purpose, the cells were cultured in six-well plates and cells
attached to the plate were collected with trypsin and mixed with detached
cells present in the supernatant. The cells were then centrifuged and resus-
pended in a solution containing 50 mg/ml propidium iodide (PI; Sigmae
Aldrich), 1 mg/ml RNAse A (SigmaeAldrich), 0.01% NP-40 (SigmaeAldrich)
in phosphate buffered saline (PBS). The cells were then incubated at 4C for
30 min in the dark and analyzed by ﬂow cytometry on FACScan (BD) using
a 560 nm dichromatic mirror and 600 nm band pass ﬁlter. The percentage of
cells with decreased DNA staining, which were apoptotic cells resulting from
either fragmentation or decreased chromatin in a minimum of 20,000 cells
per experimental condition, was determined. The data are expressed as
the percentage of apoptotic (hypodiploid) nuclei. Cells with a very low DNA
content, in which the type of cell death could not be ascertained, were ex-
cluded from the analysis. As assayed by ﬂow cytometry, none of the solvents
used for the different compounds at any dose used in our experimental con-
ditions induced any signiﬁcant degree of apoptosis.MORPHOLOGICAL EVIDENCE OF APOPTOSISFor morphological studies, chondrocytes were cultured in eight-well slides
(Costar) and treated with Ro, Roþ IL-1b and Roþ TNF-a for 8 h. The cells
were then washed with PBS, ﬁxed in 10% formalin buffered saline for
10 min, stained with 40,6-dianidino-2-phenylindole dihydrochloride (DAPI;
2 mg/ml, SigmaeAldrich) for 30 min at 37C, mounted in 90% glycerol/
PBS, and observed by ﬂuorescence microscopy.WESTERN BLOTAfter appropriate stimulation, cells were washed in ice-cold PBS, pH 7.5,
and lysed in 0.2 M TriseHCl, pH 6.8, containing 2% sodium dodecyl sulfate
(SDS), 20% glycerol, 1 mg/ml cocktail inhibitor (SigmaeAldrich) and 1 mM
phenyl methyl sulfonyl ﬂuoride (PMSF, SigmaeAldrich). Whole cell lysates
were boiled for 5 min and protein concentrations were determined using a bi-
cinchoninic acid (BCA) reagent assay (Pierce Chemical Co., Rockford, IL,
USA). Protein extracts (30 mg) were resolved on 12.5% SDS-polyacrylamide
gels and transferred to polyvinylidene diﬂuoride membranes (Immobilon P,
Millipore Co., Bedford, MA, USA). Membranes were blocked in Tris-buffered
saline, pH 7.4 containing 0.1% Tween-20, and 5% non fat dried milk for
60 min at room temperature, then incubated overnight with anti-caspase-8
(anti-human caspase-8, 1:700; MBL International, Woburn, MA, USA), anti-
caspase-3 (mouse anti-human caspase-3, 1:2000), anti-caspase-7 (mouse
anti-human caspase-7, 1:1000; BD, Madrid Spain), or anti-Bcl-2 (mouse
anti-human Bcl-2; R&D, Abingdon, UK) at 4C. After washing, the mem-
branes were incubated with peroxidase-conjugated secondary antibodies
and developed using an enhanced chemiluminescence (ECL) chemilumi-
nescence kit (Amersham Biosciences/GE Healthcare, Barcelona, Spain).
In order to assure that equal amounts of total proteins were loaded, we
also hybridized each membrane with anti-tubuline (Sigma).FLUORESCEIN ACTIVE CASPASE-3 ASSAYThe assay utilizes caspase-3 inhibitor (Z-DEVD-FMK) and caspase-8 in-
hibitor (Z-IETD-FMK) conjugated to ﬂuorescein isothiocyanate (FITC) as the
ﬂuorescent in situ marker (BioVision Research Products, Mountain View,
CA, USA). FITC-Z-DEVD-FMK and FITC-Z-IETD-FMK are cell permeable,
non toxic and irreversibly bind to activated caspase-8 and -3 in apoptotic
cells. The FITC label allows the direct detection of activated caspases in
apoptotic cells by ﬂow cytometry. After stimulation, the cells were washed
in saline solution and incubated for 1 h with 1 ml FITC-Z-DEVD-FMK or
FITC-Z-IETD-FMK at 37C in 5% CO2. A FACScan (Becton and Dickinson,
Mountain View, CA, USA) with a ﬂuorescein channel (FL1) detector, was
used for the analysis.QUANTIFICATION OF PGE2The amount of prostaglandin E2 (PGE2) in the conditioned media was
determined by a commercially available enzyme-linked immunosorbent as-
say (ELISA) kit (Amersham Biosciences) according to the manufacturer’s in-
structions. The sensitivity of the assay was 40 pg/ml, and the working range
was between 50 and 6400 pg/ml.STATISTICAL ANALYSESThe data are expressed as the mean standard error of the mean (S.E.M.)
from determinations (n) or as representative results, as indicated. The statis-
tical software program SPSS (version 12.0, SPSS, Chicago, IL, USA) was
717Osteoarthritis and Cartilage Vol. 16, No. 6used to perform analysis of variance (ANOVA) or Tukey tests. Differences
were considered to be statistically signiﬁcant at P< 0.05.
ResultsIL-1b AND TNF-a DIFFERENTIALLY REGULATE CELL DEATH
INDUCED BY RO 31-8220 (RO) IN HUMAN CHONDROCYTESThe stimulation of chondrocytes with the combination of
TNF-a (10 ng/ml) and Ro (10 mM) signiﬁcantly increased
the hypodiploid peak induced by Ro (Ro: 7.99 5.3%;
TNF-aþRo: 23.05 7.3%, n¼ 3, P< 0.0001) at 24 h. In
contrast, IL-1b (5 ng/ml) did not modify the effect of Ro in
chondrocyte survival (IL-1bþRo: 5.93 3.93%, n¼ 3,
P> 0.05). Interestingly, IL-1bþRo and TNF-aþRo
showed a signiﬁcant difference in the percentage of hypo-
diploid cells (P¼<0.0001) [Fig. 1(A)]. The morphological
analysis of nuclei by immunoﬂuorescence demonstrated
that the treatment with TNF-aþRo produced a large num-
ber of cells with condensed and fragmented nuclei;Fig. 1. Differential interaction of IL-1b and TNF-a with the cell death stim
content in PI-stained cells were made in human chondrocytes that wer
(10 ng/ml), Ro (10 mM), or treated with IL-1b and Ro (5 ng/ml and 10 mM,
The data represent the mean S.E.M. of the percentage of cells with hypo
(*P< 0.0001 vs IL-1bþRo). (B) Morphological studies using DAPI show
chondrocytes treated with Thowever, these morphologic changes in the nuclei were
not observed with IL-1bþRo treatment [Fig. 1(B)].EFFECT OF IL-1b AND TNF-a ON CASPASE FAMILY
PROTEINS IN HUMAN CHONDROCYTESThe expression of 35-kD and 33-kD unprocessed frag-
ments of pro-caspase-7 and pro-caspase-3, respectively,
was up-regulated in cultured chondrocyte cells after treat-
ment with either TNF-a or IL-1b [Fig. 2(A)]. The combination
of TNF-aþRo decreased the level of 55-kD fragment of
caspase-8, fragments of caspase-7 (35-kD) and caspase-
3 (33-kD) were also clearly reduced in chondrocytes treated
with TNF-aþRo. However, IL-1bþRo did not induce any
modiﬁcation in those fragments of pro-caspase-8, pro-
caspase-7 or pro-caspase-3 [Fig. 2(A)]. Because reduc-
tion of pro-caspase fragments can not be interpreted as
caspase activation we have carried out experiments
showing that the inhibition of caspase-8 activity revertedulator Ro 31-8220 (Ro). (A) Flow cytometry analyses of the DNA
e incubated in six-well plates for 24 h with IL-1b (5 ng/ml), TNF-a
respectively) or TNF-a and Ro (10 ng/ml and 10 mM, respectively).
diploid DNA content of three independent experiments in triplicate
ed cellular changes characteristic of apoptosis in normal human
NF-a and Ro for 8 h.
Fig. 2. Role of caspases family proteins in cell death difference be-
tween chondrocytes treated with IL-1b and TNF-a. (A) Aliquots of
total cell lysates were ﬁrst subjected to sodium dodecyl sulfate-
polyacrilamide gel electrophoresis (SDS-PAGE); immunoblotting
was performed using anti-caspase-8, -7 and -3 as described in
Methods. Proteins were isolated from untreated cells, cells treated
with IL-1b (5 ng/ml) or TNF-a (10 ng/ml), with or without Ro 31-8220
(Ro; 10 mM) for 18 h. Molecular size markers are shown on the
right. Data are representative of three separate experiments. (B)
Conﬂuent chondrocytes were pre-incubated for 2 h with caspase-8
inhibitor and then stimulated with IL-1b or TNF-a or Ro 31-8220
(10 mM) or treated with IL-1b and Ro or TNF-a and Ro for 18 h. Ali-
quots of total cell lysateswere subjected toSDS-PAGE; immunoblot-
ting was performed using anti-caspase-3 antibody as described
under Methods. Molecular size markers are shown on the left. Data
are representative of three separate experiments.
Fig. 3. Differential caspase activation in human chondrocytes
treated with IL-1b and TNF-a (A and B). Flow cytometry quantiﬁca-
tion of active caspase-3 and -8 was made in human chondrocytes
that were incubated in six-well plates for 18 h with IL-1b (5 ng/ml),
TNF-a (10 ng/ml), Ro (10 mM), or treated with IL-1b and Ro (5 ng/ml
and 10 mM, respectively) or TNF-a and Ro (10 ng/ml and 10 mM, re-
spectively). The combination of TNF-aþRo signiﬁcantly increased
the active fragments of caspase-3 (*P< 0.01) and -8 compared to
IL-1b and Ro. Data represent the mean S.E.M. of the percentage of
cells with active caspase-3 of three independent experiments in tripli-
cate and data represent the percentage of cells with active caspase-8
of one experiment.
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[Fig. 2(B)].
In order to conﬁrm activation of the caspases, we also
evaluated the active forms of caspase-3 and caspase-8
by ﬂow cytometry. The results indicated that, at 18 h, Ro
(10 mM) induced a slight increment in caspase-3 and cas-
pase-8 activity compared to the basal level. The combina-
tion of TNF-aþRo signiﬁcantly increased the active
fragments of caspase-3 and caspase-8 compared to Ro
[Fig. 3(A) and (B)]. However, IL-1bþRo did not activate
caspase-3 and caspase-8 when compared to Ro
[Fig. 3(A) and (B)].ROLE OF BCL-2 AND THE CASPASES IN THE DIFFERENTIAL
EFFECT OF IL-1b AND TNF-aTo elucidate the different effects of TNF-a and IL-1b in
the apoptotic model using Ro, we ﬁrst analyzed the role
of Bcl-2, an anti-apoptotic protein. The results showed
that both cytokines, TNF-a and IL-1b, induced Bcl-2 protein
expression in human chondrocytes (Fig. 4). However, whenRo was present, neither TNF-a nor IL-1b modiﬁed the level
of Bcl-2 (Fig. 4). These results suggest that Bcl-2 is not the
cause of the differential effects of IL-1b and TNF-a in this
in vitro model of cell death.
To elucidate the role of the caspases on the effect of
TNF-a on chondrocyte survival, we employed inhibitors of
caspase-3 (Ic3), caspase-3/7 (Ic3-7), caspase-8 (Ic8), and
a pan-caspase inhibitor (Icgen). The results showed that
pre-incubation for 2 h with all the caspase inhibitors signiﬁ-
cantly decreased the hypodiploid DNA peak induced by
stimulation with Ro (10 mM)þ TNF-a (10 ng/ml) for 24 h
(TNF-aþRo¼ 17.04 1.15%; TNF-aþRoþ Ic3¼ 2.86
0.60%; TNF-aþRoþ Ic3-7¼ 5.93 3.45%; TNF-aþRo
þ Ic8¼ 3.46 1.11%; TNF-aþRoþ Icgen¼ 2.96 0.66%,
n¼ 3, P< 0.0001) (Fig. 5).IMPLICATION OF PGE2 IN THE DIFFERENTIAL
EFFECTS OF IL-1b AND TNF-aProstaglandins participate in the pathogenesis of carti-
lage degradation. In human articular chondrocytes treat-
ment with IL-b at 5 ng/ml for 24 h induced signiﬁcantly
Fig. 4. The effects of treatment with IL-1b and TNF-a on Bcl-2 pro-
tein expression by human chondrocytes. Conﬂuent chondrocytes
were incubated for 18 h and proteins were isolated from untreated
cells, cells treated with IL-1b (5 ng/ml) or TNF-a (10 ng/ml), with or
Ro 31-8220 (Ro; 10 mM) for 18 h. Aliquots of total cell lysates were
subjected to SDS-PAGE; immunoblotting was performed using
anti-Bcl-2 antibody as described under Methods. Molecular size
markers are shown on the right. The data are representative of
three separate experiments.
719Osteoarthritis and Cartilage Vol. 16, No. 6higher levels of PGE2 than did TNF-a at 10 ng/ml
(basal¼ 4.67; IL-1¼ 304.1; TNF-a¼ 6.7 pg/ml, P< 0.0001)
[Fig. 6(A)]. When Ro was present in the medium, PGE2-
induction by IL-b was signiﬁcantly reduced to near basal
levels (11.77 pg/ml; P< 0.0001) [Fig. 6(A)]. PGE2-induction
by TNF-a was not modiﬁed by Ro [Fig. 6(A)]. To investigate
whether prostaglandins other than PGE2 contribute to the
differing responses of IL-b and TNF-a to the apoptosis
induced by Ro, we carried out experiments employing
indomethacin. The results demonstrated that indomethacin
at 100 mM increased the percentage of apoptotic chondro-
cytes induced by IL-bþRo (IL-bþRo¼ 8.43%; IL-bþ
Roþ indomethacin¼ 16.45%; n¼ 3, P< 0.01). However,
apoptosis induced by TNF-aþRo was not modiﬁed by
indomethacin [Fig. 6(B)].Discussion
In this report, we have demonstrated that both TNF-a and
IL-1b, in combination with an inhibitor of MKP-1,Fig. 5. Role of the caspases in the interaction of TNF-a with the cell death
content of PI-stained chondrocytes pre-incubated for 2 h with inhibitors (1
a pan-caspase inhibitor (Icgen); the cells were then stimulated with Ro (1
signiﬁcantly decreased the hypodiploid DNA peak induced by stimulation
inhibitors and **P< 0.0001 vs Roþ TNF-a). Values are the medifferentially regulate the activation of the apopototic path-
way in human chondrocyte cells.
We employed an in vitro model with Ro 31-8220 (Ro) to
study the apoptosis of chondrocytes. Ro inhibits MKP-1,
which is responsible for suppressing prolonged activation
of JNK in some cells, thereby protecting them from apopto-
sis18,19. In this model Ro induced apoptosis in 10% of
human chondrocytes. The combined treatment with TNF-a
and Ro caused increased cell death in a dose- and time-
dependent manner, that, interestingly, was not found using
IL-1b with Ro (data not shown). In addition, we conﬁrm that
neither cytokine alone is capable of inducing cell death. Our
results have demonstrated that the increase in the hypodip-
loid DNA peak and DNA fragmentation induced by Ro was
ampliﬁed by TNF-a, but not by IL-1b. When the activity of
caspase-3 and capase-8 was evaluated, we found that
the IL-1bþRo combination did not induce the increase in
the activation of caspase-3 and caspase-8 that was
observed by incubation with TNF-aþRo.
To further deﬁne the molecular mechanisms of sensitiza-
tion to IL-1b and TNF-a-induced apoptosis we analyzed
three candidates: Bcl-2 protein, the caspases and prosta-
glandins, speciﬁcally PGE2. It has been reported that both
TNF-a and IL-1b induce the anti-apoptotic family, Bcl-2, in
chondrocytes6,7,20. In this work we demonstrated that Bcl-
2 similarly decreased in the presence of IL-1bþRo and
TNF-aþRo. Similar results were obtained when Mcl-1
(an anti-apoptotic protein) was studied (data not shown).
This would seem to indicate that Bcl-2 and Mcl-1 are not re-
sponsible for the difference between the abilities of IL-1b
and TNF-a to initiate pro-apoptotic signaling cascades.
TNF-a is known to induce apoptosis in diverse cells
through the recruitment of caspase-3. It has been previously
described that TNF-a/ActD-induced cell death occurred by
apoptosis and that it was associated with caspase activa-
tion7,21. In this study, we investigated the relative con-
tribution of the caspases to IL-1b- and TNF-a-induced cell
death in the presence of Ro. The results showed that
TNF-a, but not IL-1b, increases caspase-3 and -8 activities.
Furthermore, cell death was signiﬁcantly inhibited by a cas-
pase-8 inhibitor and a caspase-3 inhibitor in TNF-aþRo-
treated chondrocytes, conﬁrming that cell death induced
by TNF-aþRo is caspase-dependent. Although IL-1 in-
creased the basal level of pro-caspases -3, -7 and -8, IL-1
did not modify the apoptosis induced by Ro. This ﬁnding isstimulator, Ro 31-8220 (Ro). Flow cytometry analyses of the DNA
00 mM) of caspase-3 (Ic3), caspase-3/7 (Ic3-7), caspase-8 (Ic8) or
0 mM)þ TNF-a (10 ng/ml) for 24 h. All the inhibitors of the caspases
with Roþ TNF-a (*P< 0.0001 vs basal untreated cells and caspase
ans S.E.M. of three experiments performed in duplicate.
Fig. 6. Implication of PGE2 in the differential interaction of IL-1b and TNF-a with the cell death stimulator, Ro 31-8220 (Ro). (A) The amounts of
PGE2 in the conditioned media of chondrocytes incubated in medium alone or treated with IL-1b (5 ng/ml) or TNF-a (10 ng/ml), with or without
Ro (10 mM), were determined at 18 h by an enzyme-linked immunosorbent assay. PGE2 levels are expressed as the mean S.E.M. of four
experiments performed in duplicate (IL-1b vs basal and TNF-a, *P< 0.0001; IL-1b vs Roþ IL-1b, **P< 0.0001). (B) Flow cytometric analysis
of the DNA content of PI-stained chondrocytes pretreated with the COX inhibitor, indomethacin (100 mM), for 2 h, followed by co-incubation
with IL-1bþRo or TNF-aþRo for an additional 24 h. Indomethacin pretreatment increased the percentage of apoptotic chondrocytes induced
by IL-bþRo (*P< 0.05 vs Roþ IL-1b). The data represent the mean S.E.M. of the percentage of cells with hypodiploid DNA content of four
independent experiments in duplicate.
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of pro-caspase when IL-1 was combined with Ro. These re-
sults indicate possibly different requirements for the cas-
pases during TNF-aþRo or IL-1bþRo interactions.
Few studies have used the same model to examine the
differential effect of IL-1 and TNF on chondrocytes survival.
Recently, a study investigating the interaction between
TNF and IL-1 in an animal model was reported22. These
authors suggest that TNF-mediated cartilage damage is
completely dependent on IL-1. Our results are in concor-
dance with the ﬁndings of this study, conﬁrming that TNF
plays an important role in chondrocyte death. We have
not determined whether the ﬁnal effect of TNF in chon-
drocyte death is IL-1 dependent. However, our results
support the idea that IL-1 alone is not enough to induce
death in chondrocytes. Perhaps IL-1 needs a co-factor
induced by TNF or by indomethacin to induce apoptosis
in chondrocytes.
Multiple reports have shown that PGE2 plays a crucial
role in the pathogenesis of OA23,24. Increased COX-2 ex-
pression has been reported in cartilage and synovial tissues
from patients with OA or rheumatoid arthritis (RA), and also
in several models of cartilage degradation23e25. Someﬁndings suggest that PGE2 mediates the IL-1b effect on
cartilage degradation26; however, PGE2 may also have
positive effects on cartilage by increasing the level of gluco-
corticoid receptors in chondrocyte cells, inﬂuencing carti-
lage differentiation and proliferation, and mediating the
effects of vitamin D on cartilage27. Similar results were
found in our previous studies using the actinomycin model
and from another report that found that TNF-a-mediated
protection of chondrocytes from NO-induced apoptosis re-
quires COX-2 activity28. Whether PGE2 causes cell death
is highly controversial6,28e30. In our study, we found that
the levels of PGE2 induced by IL-1b were much higher
than those induced by TNF-a. Interestingly, when Ro was
present in the culture medium, the IL-1b-induced PGE2
levels were signiﬁcantly reduced to near basal levels. This
suggests that PGE2 levels do not play a role in the apopto-
sis induced in chondrocytes by IL-1þRo. We then exam-
ined, by the inhibition of endogenous prostaglandin
synthesis, whether other molecules synthesized by COX
could contribute to the different effects of IL-1b and TNF-a
on cell death. We found that indomethacin resulted in
an increase in cell death induced by IL-b in the presence
of Ro [Fig. 5(B)]. These data suggest that the synthesis of
721Osteoarthritis and Cartilage Vol. 16, No. 6some molecules inhibited by indomethacin could explain
the different effects of IL-1 and TNF on chondrocyte death.
Similarly, it has recently been established that the mito-
chondrial protein, Smac/Diablo, is essential for the apopto-
sis induced by non-steroidal anti-inﬂammatory drugs
(NSAIDs) in colon cancer cells31. It has also been reported
that 15-deoxy-D12,14-prostaglandin J2 (15d-PGJ2), a natural
ligand of the peroxisome proliferator-activated receptor-g
(PPARg), has an anti-apoptotic effect on chondrocytes
and also synovial ﬁbroblasts through inhibition of ERK1/2
phosphorylation32.
The clinical relevance of the results of this study is focused
on at least two therapeutic areas in OA treatment. One area
is support for the idea that indomethacin (a classical NSAID)
may in some circumstances, such as high levels of IL-1 and
inhibition of the MKP-1 pathway, cause damage to articular
cartilage. This may explain the accelerated destructive effect
of indomethacin in hip OA described several years ago33.
Another consideration from our results is that the blocking
of cytokines such as TNF-a may prove clinically useful for
prevention of cartilage degradation in OA.
In summary, this set of studies provides evidence that
both TNF-a and IL-1b, in combination with an inhibitor of
MKP-1, differentially regulate the activation of the apopo-
totic pathway in human chondrocyte cells. Furthermore,
PGE2 does not modulate apoptosis in this in vitro model
and indomethacin increases the apoptosis induced by
IL-1þRo. These data are important for a better under-
standing of the participation of TNF-a and IL-1b in the path-
ogenesis of cartilage degradation and may provide new
clues for understanding the treatment of OA with cytokine
antagonists.Conﬂict of interest
The authors have no conﬂict of interest.Acknowledgments
We are grateful to Ms Pilar Cal Purrin˜os for her expert
secretarial assistance. The authors express appreciation
to Dr Manuel Ramallal and Lourdes Sanjurjo from the
Orthopaedic Department of the CHU Juan Canalejo for pro-
viding cartilage samples.
This study was supported by grants from Fondo Investiga-
cio´n Sanitaria-Spain: PI06-1670; Secretarı´a IþDþI- Xunta
de Galicia: PGIDIT06PXIB916357PR and Ministerio de
Educacio´n y Ciencia: SAF 2005-06211.
M. J. Lo´pez-Armada was supported by Contrato Investiga-
dores SNS (Fondo Investigacio´n Sanitaria, Spain, CP06/
00292). M. Lires-Dean and B. Cillero-Pastor are the recipi-
ents of a grant from the Fondo Investigacion Sanitaria
(BF03/00616 and FI05/00261, respectively).References
1. Blanco FJ, Guitian R, Vazquez-Martul E, de Toro FJ, Galdo F. Osteoar-
thritis chondrocytes die by apoptosis. A possible pathway for osteoar-
thritis pathology. Arthritis Rheum 1998;41:284e9.
2. Maneiro E, Martin MA, de Andres MC, Lopez-Armada MJ, Fernandez-
Sueiro JL, del Hoyo P, et al. Mitochondrial respiratory activity is
altered in osteoarthritic human articular chondrocytes. Arthritis Rheum
2003;48:700e8.
3. Abramson SB, Amin A. Blocking the effects of IL-1 in rheumatoid arthritis
protects bone and cartilage. Rheumatology 2002;41:972e80.
(Review).4. Lotz M, Blanco FJ, von Kempis J, Dudler J, Maier R, Villiger PM, et al.
Cytokine regulation of chondrocyte functions. J Rheumatol Suppl
1995;43:104e8.
5. Blanco FJ, Geng Y, Lotz M. Differentiation-dependent effects of IL-1 and
TGF-beta on human articular chondrocyte proliferation are related to in-
ducible nitric oxide synthase expression. J Immunol 1995;154:
4018e26.
6. Ku¨hn K, Hashimoto S, Lotz M. IL-1b protects human chondrocytes from
CD95-induced apoptosis. J Immunol 2000;164:2233e9.
7. Lo´pez-Armada MJ, Carame´s B, Lires-Dea´n M, Cillero-Pastor B, Ruiz-
Romero C, Galdo F, et al. Cytokines, tumour necrosis factor-alpha
and interleukin-1beta, differentially regulate apoptosis in osteoarthritis
cultured human chondrocytes. Osteoarthritis Cartilage 2006;14:
660e9.
8. Park YW, Ji JD, Lee JS, Ryang DW, Yoo DH. Actinomycin D renders
cultured synovial ﬁbroblasts susceptible to tumour necrosis factor re-
lated apoptosis-inducing ligand (TRAIL)-induced apoptosis. Scand J
Rheumatol 2003;32:356e63.
9. Baichwal VR, Baeuerle PA. Activate NF-kB or die? Curr Biol 1997;7:
R94e6 (Review).
10. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of
TNF-alpha-induced apoptosis by NF-kappaB. Science 1996;274:
787e9.
11. Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E, et al.
Mitogen-activated protein kinase-mediated Fas apoptotic signaling
pathway. Proc Natl Acad Sci USA 1997;94:3302e7.
12. Kolberg R. Tangled pathways: new roles for NF-kB, TNF-a in apoptosis.
J NIH Res 1997;9:29e32.
13. Wong GH, Elwell JH, Oberley LW, Goeddel DV. Manganous superoxide
dismutase is essential for cellular resistance to cytotoxicity of tumor
necrosis factor. Cell 1989;58:923e31.
14. Opipari AW Jr, Hu HM, Yabkowitz R, Dixit VM. The A20 zinc ﬁnger pro-
tein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem
1992;267:12424e7.
15. Grimm S, Bauer MK, Baeuerle PA, Schulze-Osthoff K. Bcl-2 down-
regulates the activity of transcription factor NF-kappaB induced
upon apoptosis. J Cell Biol 1996;134:13e23.
16. Karsan A, Yee E, Harlan JM. Endothelial cell death induced by tumor
necrosis factor-alpha is inhibited by the Bcl-2 family member, A1. J
Biol Chem 1996;271:27201e4.
17. Franklin CC, Srikanth S, Kraft AS. Conditional expression of mitogen-
activated protein kinase phosphatase-1, MKP-1, is cytoprotective
against UV-induced apoptosis. Proc Natl Acad Sci USA 1998;95:
3014e9.
18. Yoon HS, Kim HA. Prolongation of c-Jun N-terminal kinase is associated
with cell death induced by tumor necrosis factor alpha in human chon-
drocytes. J Korean Med Sci 2004;19:567e73.
19. Guo YL, Kang B, Williamson JR. Resistance to TNF-alpha cytotoxicity
can be achieved through different signaling pathways in rat mesangial
cells. Am J Physiol 1999;276(2 Pt 1):C435e41.
20. Lo´pez-Armada MJ, Carame´s B, Martin MA, Cillero-Pastor B, Lires-
Dea´n M, Fuentes-Boquete I, et al. Mitochondrial activity is modulated
by TNFalpha and IL-1beta in normal human chondrocyte cells. Oste-
oarthritis Cartilage 2006;14:1011e22.
21. Kim H A, Song Y W. TNF-alpha-mediated apoptosis in chondrocytes
sensitized by MG132 or actinomycin D. Biochem Biophys Res Com-
mun 2002;295:937e44.
22. Zwerina J, Redlich K, Polzer K, Joosten L, Kronke G, Distler J, et al.
TNF-induced structural joint damage is mediated by IL-1. Proc Natl
Acad Sci USA 2007;104:11742e7.
23. Amin AR, Attur M, Patel RN, Thakker GD, Marshall PJ, Rediske J, et al.
Superinduction of cyclooxygenase-2 activity in human osteoarthritis-
affected cartilage. Inﬂuence of nitric oxide. J Clin Invest 1997;99:
1231e7.
24. Martel-Pelletier J, Pelletier JP, Fahmi H. Cyclooxygenase-2 and prosta-
glandins in articular tissues. Semin Arthritis Rheum 2003;33:
155e67.
25. Kobayashi T, Okamoto K, Kobata T, Hasunuma T, Sumida T,
Nishioka K. Tumor necrosis factor alpha regulation of the FAS-
mediated apoptosis-signalling pathway in synovial cells. Arthritis
Rheum 1999;42:519e26.
26. Blanco FJ, Guitian R, Moreno J, de Toro FJ, Galdo F. Effect of anti-
inﬂammatory drugs on COX-1 and COX-2 activity in human articular
chondrocytes. J Rheumatol 1999;26:1366e73.
27. DiBattista JA, Martel-Pelletier J, Cloutier JM, Pelletier JP. Modulation
of glucocorticoid receptor expression in human articular chondro-
cytes by cAMP and prostaglandins. J Rheumatol Suppl 1991;27:
102e5.
28. Relic B, Bentires-Alj M, Ribbens C, Franchimont N, Guerne PA,
Benoit V, et al. TNF-a protects human primary articular chondrocytes
from nitric oxide-induced apoptosis via nuclear factor-kappaB. Lab
Invest 2002;82:1661e72.
722 B. Carame´s et al.: Differential effects of cytokines on cell death29. Notoya K, Jovanovic DV, Reboul P, Martel-Pelletier J, Mineau F,
Pelletier JP. The induction of cell death in human osteoarthritis chon-
drocytes by nitric oxide is related to the production of prostaglandin
E2 via the induction of cyclooxygenase-2. J Immunol 2000;165:
3402e10.
30. Chan TA, Morin PJ, Vogelstein B, Kinzler KW. Mechanisms underlying
nonsteroidal anti-inﬂammatory drug-mediated apoptosis. Proc Natl
Acad Sci USA 1998;95:681e6.
31. Kohli M, Yu J, Seaman C, Bardelli A, Kinzler KW, Vogelstein B, et al.
SMAC/Diablo-dependent apoptosis induced by nonsteroidalantiinﬂammatory drugs (NSAIDs) in colon cancer cells. Proc Natl
Acad Sci USA 2004;101:16897e902.
32. Relic B, Benoit V, Franchimont N, Ribbens C, Kaiser MJ, Gillet P, et al.
15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced
sustained extracellular signal-regulated kinase phosphorylation and
apoptosis in human articular chondrocytes and synovial ﬁbroblasts.
J Biol Chem 2004;279:22399e403.
33. Rashad S, Revell P, Hemingway A, Low F, Rainsford K, Walker F. Effect
of non-steroidal anti-inﬂammatory drugs on the course of osteoarthri-
tis. Lancet 1989;2(8662):519e22.
